This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Contract Research Organizations (CROs) Market To 2018 - Public-Private Partnerships To Strengthen Research Capacities And Advance Clinical Development Programs

Figure 45: Contract Research Organization Market to 2018, InCrom, Company Profile, 2011 73

Figure 46: Contract Research Organization Market to 2018, Pharmaron, Company Profile, 2011 74

Figure 47: Contract Research Organization Market to 2018, Venturepharm Service Group, Company Profile, 2011 75

Figure 48: Contract Research Organization Market to 2018, Market Share Analysis of Contract Research Organizations (%), 2011 76

Figure 49: Contract Research Organization Market to 2018, Quintiles, Snapshot, 2011 78

Figure 50: Contract Research Organization Market to 2018, Covance, Snapshot, 2011 81

Figure 51: Top 20 Contract Research Organizations, ICON, Snapshot, 2011 83

Figure 52: Contract Research Organization Market to 2018, Pharmaceutical Product Development, Snapshot, 2011 85

Figure 53: Contract Research Organization Market to 2018, Charles River Laboratories, Snapshot, 2011 88

Figure 54: Contract Research Organization Market to 2018, Parexel, Snapshot, 2011 90

Companies Mentioned

Quintiles Transnational Corp

Covance Inc

Pharmaceutical Product Development Inc

Charles River Laboratories International, Inc

Parexel International

To order this report: Drug_Discovery_and_Development Industry: Contract Research Organizations (CROs) Market to 2018 - Public-Private Partnerships to Strengthen Research Capacities and Advance Clinical Development Programs

Contact Clare:

US:(339) 368 6001

Intl:+1 339 368 6001

SOURCE Reportlinker

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
6 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.54 -0.51%
FB $98.04 -5.80%
GOOG $667.50 -2.40%
TSLA $147.44 -9.30%
YHOO $26.89 -3.90%


Chart of I:DJI
DOW 15,823.23 -381.74 -2.36%
S&P 500 1,831.59 -48.46 -2.58%
NASDAQ 4,223.8970 -139.2470 -3.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs